Squarepoint Ops LLC Zai Lab LTD Transaction History

Squarepoint Ops LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.3 - $39.67 $680,494 - $1.07 Million	26,897 New	26,897 $745,000
Q4 2022 Feb 14, 2023	BUY	$22.28 - $38.71 $358,373 - $622,650	16,085 New	16,085 $493,000
Q1 2022 May 16, 2022	SELL	$27.77 - $64.4 $227,519 - $527,629	-8,193 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $569,367 - $1.09 Million	-10,371 Reduced 55.87%	8,193 $515,000
Q3 2021 Nov 15, 2021	SELL	$105.0 - $178.37 $22,890 - $38,884	-218 Reduced 1.16%	18,564 $1.96 Million
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $1.75 Million - $2.52 Million	14,001 Added 292.85%	18,782 $3.32 Million
Q1 2021 May 17, 2021	BUY	$126.27 - $191.71 $603,696 - $916,565	4,781 New	4,781 $638,000
Q2 2020 Aug 14, 2020	SELL	$48.82 - $82.53 $270,072 - $456,555	-5,532 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$39.1 - $62.9 $216,301 - $347,962	5,532 New	5,532 $285,000
Q1 2019 May 15, 2019	SELL	$21.71 - $31.54 $190,483 - $276,731	-8,774 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$14.95 - $24.72 $50,815 - $84,023	-3,399 Reduced 27.92%	8,774 $204,000
Q3 2018 Nov 14, 2018	BUY	$17.8 - $25.35 $216,679 - $308,585	12,173 New	12,173 $237,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.43B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.